MARKET

TLRY

TLRY

TILRAY, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.01
-0.02
-0.17%
After Hours: 12.01 0 0.00% 19:57 09/16 EDT
OPEN
12.00
PREV CLOSE
12.03
HIGH
12.24
LOW
11.90
VOLUME
9.32M
TURNOVER
--
52 WEEK HIGH
67.00
52 WEEK LOW
4.410
MARKET CAP
5.40B
P/E (TTM)
-8.8108
1D
5D
1M
3M
1Y
5Y
Analyst: Updating Tilray's Numbers Ahead Of Aug Qtr Print
Cantor Fitzgerald analyst Pablo Zuanic shared an update on Tilray's (NASDAQ: TLRY) Aug qtr sales estimates in his Thursday note.
Benzinga · 2h ago
Tilray, Inc. (TLRY) Dips More Than Broader Markets: What You Should Know
Zacks.com · 4h ago
Tilray Stock Attempts Bullish Reversal Following New Hampshire Legalization News
Tilray Inc (NASDAQ: TLRY) broke up from a descending channel Benzinga called out but then fell down to backtest the upper descending trendline of the cha
Benzinga · 9h ago
3 Cannabis Stocks to Buy Despite the Selloff
Investor Place · 12h ago
--Roth Capital Adjusts Tilray Inc PT to $12 From $25, Maintains Neutral Rating
MT Newswires · 14h ago
Is Tilray Stock A Buy After Key Shareholder Vote?
Canadian pot producer Tilray in August said it had invested in U.S. cannabis retailer MedMen. Should you buy TLRY stock now?
Investor's Business Daily · 1d ago
Cannabidiol Market Size Passed $7 Billion In 2020, Estimated To Grow At Over 35% CAGR Between 2021 And 2027 - Financial News Media
Palm Beach, FL - September 15, 2021 - FinancialNewsMedia.com News Commentary – The CBD isolate market has been growing even before the pandemic appeared. While some areas of the healthcare sector remain to be impacted, the CBD sales have increased since th...
MENAFN · 1d ago
'Washington State Activists Announce 2022 Drug Decriminalization Ballot Campaign' -Marijuana Moment Report
https://newsdesk-tools-v3.benzinga.com/postbox
Benzinga · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TLRY. Analyze the recent business situations of TILRAY, INC. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TLRY stock price target is 16.63 with a high estimate of 27.00 and a low estimate of 1.270.
EPS
Institutional Holdings
Institutions: 447
Institutional Holdings: 52.24M
% Owned: 11.63%
Shares Outstanding: 449.22M
TypeInstitutionsShares
Increased
129
10.26M
New
58
2.30M
Decreased
101
29.13M
Sold Out
88
26.11M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.24%
Pharmaceuticals & Medical Research
+0.11%
Key Executives
Chairman/President/Chief Executive Officer/Director
Irwin Simon
Non-Executive Vice Chairman/Lead Director/Independent Director
Renah Persofsky
Chief Financial Officer
Carl Merton
Chief Operating Officer
Jon Levin
Other
Denise Faltischek
Other
James Meiers
Director
Jodi Butts
Director
John Herhalt
Director
David Hopkinson
Independent Director
David Clanachan
Independent Director
Thomas Looney
Independent Director
Walter Robb
No Data
About TLRY
Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Webull offers kinds of Tilray Inc stock information, including NASDAQ:TLRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLRY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TLRY stock methods without spending real money on the virtual paper trading platform.